Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Versartis Inc (NASDAQ:VSAR)

20.15
Delayed Data
As of 4:14pm ET
 +0.45 / +2.28%
Today’s Change
6.32
Today|||52-Week Range
24.00
+35.23%
Year-to-Date
No recent news for Versartis Inc.

Today’s Trading

Previous close19.70
Today’s open19.55
Day’s range19.05 - 20.40
Volume326,328
Average volume (3 months)204,463
Market cap$690.4M
Dividend yield--
Data as of 4:14pm ET, 03/22/2017

Growth & Valuation

Earnings growth (last year)-9.51%
Earnings growth (this year)+4.31%
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book--

Competitors

 Today’s
change
Today’s
% change
TGTXTG Therapeutics Inc-0.65-5.53%
ADROAduro Biotech Inc+0.20+1.93%
HSKAHeska Corp+1.12+1.17%
CTMXCytomX Therapeutics ...+0.36+1.97%
Data as of 4:00pm ET, 03/22/2017

Financials

Next reporting dateMay 9, 2017
EPS forecast (this quarter)-$0.72
Annual revenue (last year)$0.00
Annual profit (last year)-$95.8M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Jay P. Shepard
Chief Financial Officer &
Head-Investor Relations
Joshua T. Brumm
Corporate headquarters
Menlo Park, California

Forecasts


Search for Jobs